// App-Quantinova.ai

T4256 2015 AHA : Impact on Clinical Outcomes of Randomization at Community Hospitals versus Pre-hospital Location in STEMI Patients: Insights From the STREAM Study

Researchers

Presenter

  • Patrick Goldstein

Principal Investigators

  • Antonio Carvalho

  • Miodrag C Ostojic

  • John Nanas

  • Yinggan Zheng

  • Anthony Gershlick

  • Thierry Danays

  • Frans Van de Werf

  • Paul W Armstrong

Medical Centers

  • Univ Hosp of Leicester, Leicester LE QP, United Kingdom

  • Sch of Med Univ of Belgrade, Belgrade, Serbia

  • Federal Univ. of Sao Paulo, Sao Paulo, Brazil.

  • University of Alberta, Edmonton, AB, Canada

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Univ of Athens Sch of Med, Athens, Greece

  • SAMU Regional de Lille, Cedex, France

Locations

  • Brazil

  • Canada

  • Greece

  • United Kingdom

  • France

  • Serbia

  • Belgium

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim